nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—AR—semen—acquired immunodeficiency syndrome	0.0417	0.12	CbGeAlD
Drospirenone—NR3C2—blood plasma—acquired immunodeficiency syndrome	0.0205	0.0588	CbGeAlD
Drospirenone—Thrombosis—Ritonavir—acquired immunodeficiency syndrome	0.0126	0.0193	CcSEcCtD
Drospirenone—BCHE—blood plasma—acquired immunodeficiency syndrome	0.0124	0.0354	CbGeAlD
Drospirenone—NR3C2—retina—acquired immunodeficiency syndrome	0.0112	0.0322	CbGeAlD
Drospirenone—PTGS2—endothelium—acquired immunodeficiency syndrome	0.0107	0.0307	CbGeAlD
Drospirenone—Breast pain—Ritonavir—acquired immunodeficiency syndrome	0.0102	0.0157	CcSEcCtD
Drospirenone—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00952	0.0273	CbGeAlD
Drospirenone—Migraine—Nelfinavir—acquired immunodeficiency syndrome	0.00945	0.0145	CcSEcCtD
Drospirenone—Affect lability—Nelfinavir—acquired immunodeficiency syndrome	0.00945	0.0145	CcSEcCtD
Drospirenone—Affect lability—Stavudine—acquired immunodeficiency syndrome	0.00942	0.0145	CcSEcCtD
Drospirenone—Depression—Amprenavir—acquired immunodeficiency syndrome	0.00929	0.0143	CcSEcCtD
Drospirenone—Migraine—Abacavir—acquired immunodeficiency syndrome	0.00928	0.0143	CcSEcCtD
Drospirenone—Acute coronary syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00919	0.0141	CcSEcCtD
Drospirenone—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.00914	0.014	CcSEcCtD
Drospirenone—Mood swings—Nelfinavir—acquired immunodeficiency syndrome	0.00909	0.014	CcSEcCtD
Drospirenone—Mood swings—Stavudine—acquired immunodeficiency syndrome	0.00907	0.0139	CcSEcCtD
Drospirenone—Affect lability—Zidovudine—acquired immunodeficiency syndrome	0.00819	0.0126	CcSEcCtD
Drospirenone—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.00791	0.0122	CcSEcCtD
Drospirenone—NR3C2—digestive system—acquired immunodeficiency syndrome	0.00789	0.0226	CbGeAlD
Drospirenone—Mood swings—Zidovudine—acquired immunodeficiency syndrome	0.00788	0.0121	CcSEcCtD
Drospirenone—Breast disorder—Zidovudine—acquired immunodeficiency syndrome	0.00752	0.0115	CcSEcCtD
Drospirenone—NR3C2—blood—acquired immunodeficiency syndrome	0.00751	0.0215	CbGeAlD
Drospirenone—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.00742	0.0213	CbGeAlD
Drospirenone—Depression—Stavudine—acquired immunodeficiency syndrome	0.00735	0.0113	CcSEcCtD
Drospirenone—Mental disorder—Amprenavir—acquired immunodeficiency syndrome	0.00733	0.0113	CcSEcCtD
Drospirenone—AR—skin of body—acquired immunodeficiency syndrome	0.0073	0.0209	CbGeAlD
Drospirenone—Depression—Abacavir—acquired immunodeficiency syndrome	0.00725	0.0111	CcSEcCtD
Drospirenone—NR3C2—spinal cord—acquired immunodeficiency syndrome	0.00724	0.0208	CbGeAlD
Drospirenone—Migraine—Efavirenz—acquired immunodeficiency syndrome	0.00719	0.0111	CcSEcCtD
Drospirenone—Affect lability—Efavirenz—acquired immunodeficiency syndrome	0.00719	0.0111	CcSEcCtD
Drospirenone—Acute coronary syndrome—Abacavir—acquired immunodeficiency syndrome	0.00716	0.011	CcSEcCtD
Drospirenone—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.00712	0.0109	CcSEcCtD
Drospirenone—PGR—blood—acquired immunodeficiency syndrome	0.00698	0.02	CbGeAlD
Drospirenone—NR3C2—vagina—acquired immunodeficiency syndrome	0.00696	0.02	CbGeAlD
Drospirenone—Mood swings—Efavirenz—acquired immunodeficiency syndrome	0.00692	0.0106	CcSEcCtD
Drospirenone—Migraine—Delavirdine—acquired immunodeficiency syndrome	0.00688	0.0106	CcSEcCtD
Drospirenone—Affect lability—Delavirdine—acquired immunodeficiency syndrome	0.00688	0.0106	CcSEcCtD
Drospirenone—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00668	0.0103	CcSEcCtD
Drospirenone—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00664	0.0102	CcSEcCtD
Drospirenone—Mood swings—Delavirdine—acquired immunodeficiency syndrome	0.00663	0.0102	CcSEcCtD
Drospirenone—Breast disorder—Efavirenz—acquired immunodeficiency syndrome	0.00661	0.0101	CcSEcCtD
Drospirenone—NR3C2—lung—acquired immunodeficiency syndrome	0.00659	0.0189	CbGeAlD
Drospirenone—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.00648	0.00996	CcSEcCtD
Drospirenone—PGR—vagina—acquired immunodeficiency syndrome	0.00647	0.0186	CbGeAlD
Drospirenone—Affect lability—Ritonavir—acquired immunodeficiency syndrome	0.00637	0.00978	CcSEcCtD
Drospirenone—Migraine—Ritonavir—acquired immunodeficiency syndrome	0.00637	0.00978	CcSEcCtD
Drospirenone—Cerebrovascular accident—Saquinavir—acquired immunodeficiency syndrome	0.00635	0.00976	CcSEcCtD
Drospirenone—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.00628	0.00965	CcSEcCtD
Drospirenone—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.00617	0.00948	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.00616	0.00946	CcSEcCtD
Drospirenone—Mood swings—Ritonavir—acquired immunodeficiency syndrome	0.00613	0.00941	CcSEcCtD
Drospirenone—PGR—lung—acquired immunodeficiency syndrome	0.00612	0.0176	CbGeAlD
Drospirenone—NR3C2—nervous system—acquired immunodeficiency syndrome	0.0061	0.0175	CbGeAlD
Drospirenone—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.00603	0.00926	CcSEcCtD
Drospirenone—BCHE—skin of body—acquired immunodeficiency syndrome	0.00594	0.017	CbGeAlD
Drospirenone—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.00591	0.017	CbGeAlD
Drospirenone—Acute coronary syndrome—Indinavir—acquired immunodeficiency syndrome	0.00588	0.00903	CcSEcCtD
Drospirenone—NR3C2—central nervous system—acquired immunodeficiency syndrome	0.00587	0.0168	CbGeAlD
Drospirenone—Affect lability—Lamivudine—acquired immunodeficiency syndrome	0.00585	0.00898	CcSEcCtD
Drospirenone—Migraine—Lamivudine—acquired immunodeficiency syndrome	0.00585	0.00898	CcSEcCtD
Drospirenone—Breast disorder—Ritonavir—acquired immunodeficiency syndrome	0.00584	0.00898	CcSEcCtD
Drospirenone—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.00584	0.00898	CcSEcCtD
Drospirenone—AR—digestive system—acquired immunodeficiency syndrome	0.00584	0.0167	CbGeAlD
Drospirenone—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00583	0.00896	CcSEcCtD
Drospirenone—Mental disorder—Stavudine—acquired immunodeficiency syndrome	0.0058	0.00891	CcSEcCtD
Drospirenone—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.00577	0.00887	CcSEcCtD
Drospirenone—PGR—nervous system—acquired immunodeficiency syndrome	0.00567	0.0163	CbGeAlD
Drospirenone—Mood swings—Lamivudine—acquired immunodeficiency syndrome	0.00563	0.00864	CcSEcCtD
Drospirenone—Depression—Efavirenz—acquired immunodeficiency syndrome	0.00562	0.00863	CcSEcCtD
Drospirenone—AR—blood—acquired immunodeficiency syndrome	0.00556	0.016	CbGeAlD
Drospirenone—PGR—central nervous system—acquired immunodeficiency syndrome	0.00546	0.0157	CbGeAlD
Drospirenone—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.00544	0.00836	CcSEcCtD
Drospirenone—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00538	0.00826	CcSEcCtD
Drospirenone—AR—spinal cord—acquired immunodeficiency syndrome	0.00536	0.0154	CbGeAlD
Drospirenone—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00535	0.00822	CcSEcCtD
Drospirenone—AR—vagina—acquired immunodeficiency syndrome	0.00516	0.0148	CbGeAlD
Drospirenone—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00513	0.00788	CcSEcCtD
Drospirenone—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00506	0.00777	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00505	0.00775	CcSEcCtD
Drospirenone—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.00504	0.00775	CcSEcCtD
Drospirenone—Depression—Ritonavir—acquired immunodeficiency syndrome	0.00497	0.00764	CcSEcCtD
Drospirenone—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.00491	0.00755	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00489	0.00751	CcSEcCtD
Drospirenone—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.00489	0.00751	CcSEcCtD
Drospirenone—AR—lung—acquired immunodeficiency syndrome	0.00488	0.014	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00487	0.00749	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.0048	0.00738	CcSEcCtD
Drospirenone—Depression—Saquinavir—acquired immunodeficiency syndrome	0.00478	0.00735	CcSEcCtD
Drospirenone—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.00478	0.00735	CcSEcCtD
Drospirenone—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00478	0.00734	CcSEcCtD
Drospirenone—BCHE—digestive system—acquired immunodeficiency syndrome	0.00475	0.0136	CbGeAlD
Drospirenone—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00473	0.00727	CcSEcCtD
Drospirenone—NR3C2—brain—acquired immunodeficiency syndrome	0.00466	0.0134	CbGeAlD
Drospirenone—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00461	0.00709	CcSEcCtD
Drospirenone—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00459	0.00705	CcSEcCtD
Drospirenone—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00458	0.00704	CcSEcCtD
Drospirenone—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00458	0.0131	CbGeAlD
Drospirenone—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00457	0.00703	CcSEcCtD
Drospirenone—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00457	0.00702	CcSEcCtD
Drospirenone—Depression—Lamivudine—acquired immunodeficiency syndrome	0.00456	0.00701	CcSEcCtD
Drospirenone—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00454	0.00698	CcSEcCtD
Drospirenone—BCHE—blood—acquired immunodeficiency syndrome	0.00453	0.013	CbGeAlD
Drospirenone—AR—nervous system—acquired immunodeficiency syndrome	0.00452	0.013	CbGeAlD
Drospirenone—NR3C2—lymph node—acquired immunodeficiency syndrome	0.00451	0.0129	CbGeAlD
Drospirenone—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.0045	0.00692	CcSEcCtD
Drospirenone—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.0045	0.00691	CcSEcCtD
Drospirenone—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00447	0.00687	CcSEcCtD
Drospirenone—BCHE—bone marrow—acquired immunodeficiency syndrome	0.00438	0.0126	CbGeAlD
Drospirenone—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00436	0.0125	CbGeAlD
Drospirenone—AR—central nervous system—acquired immunodeficiency syndrome	0.00435	0.0125	CbGeAlD
Drospirenone—PGR—brain—acquired immunodeficiency syndrome	0.00433	0.0124	CbGeAlD
Drospirenone—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00433	0.00665	CcSEcCtD
Drospirenone—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00431	0.00662	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00424	0.00651	CcSEcCtD
Drospirenone—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00423	0.0065	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00421	0.00646	CcSEcCtD
Drospirenone—BCHE—vagina—acquired immunodeficiency syndrome	0.0042	0.012	CbGeAlD
Drospirenone—PGR—lymph node—acquired immunodeficiency syndrome	0.00419	0.012	CbGeAlD
Drospirenone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00407	0.00626	CcSEcCtD
Drospirenone—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00407	0.00626	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00406	0.00624	CcSEcCtD
Drospirenone—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00406	0.00624	CcSEcCtD
Drospirenone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00401	0.00616	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.004	0.00615	CcSEcCtD
Drospirenone—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00397	0.0061	CcSEcCtD
Drospirenone—BCHE—lung—acquired immunodeficiency syndrome	0.00397	0.0114	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00394	0.00605	CcSEcCtD
Drospirenone—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00602	CcSEcCtD
Drospirenone—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00391	0.006	CcSEcCtD
Drospirenone—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00388	0.00597	CcSEcCtD
Drospirenone—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00377	0.0058	CcSEcCtD
Drospirenone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00373	0.00573	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.00572	CcSEcCtD
Drospirenone—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00371	0.0106	CbGeAlD
Drospirenone—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00369	0.00567	CcSEcCtD
Drospirenone—BCHE—nervous system—acquired immunodeficiency syndrome	0.00368	0.0105	CbGeAlD
Drospirenone—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00366	0.0105	CbGeAlD
Drospirenone—BCHE—central nervous system—acquired immunodeficiency syndrome	0.00354	0.0101	CbGeAlD
Drospirenone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00353	0.00542	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00353	0.00542	CcSEcCtD
Drospirenone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00352	0.00541	CcSEcCtD
Drospirenone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00349	0.00536	CcSEcCtD
Drospirenone—PTGS2—blood—acquired immunodeficiency syndrome	0.00349	0.01	CbGeAlD
Drospirenone—AR—brain—acquired immunodeficiency syndrome	0.00345	0.0099	CbGeAlD
Drospirenone—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00338	0.00968	CbGeAlD
Drospirenone—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.00336	0.00963	CbGeAlD
Drospirenone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00334	0.00513	CcSEcCtD
Drospirenone—AR—lymph node—acquired immunodeficiency syndrome	0.00334	0.00957	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00329	0.00506	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00328	0.00504	CcSEcCtD
Drospirenone—PTGS2—vagina—acquired immunodeficiency syndrome	0.00323	0.00927	CbGeAlD
Drospirenone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00322	0.00494	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00487	CcSEcCtD
Drospirenone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00312	0.00479	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.0031	0.00477	CcSEcCtD
Drospirenone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00309	0.00474	CcSEcCtD
Drospirenone—PTGS2—lung—acquired immunodeficiency syndrome	0.00306	0.00877	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00302	0.00465	CcSEcCtD
Drospirenone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.003	0.00461	CcSEcCtD
Drospirenone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00297	0.00457	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00297	0.00456	CcSEcCtD
Drospirenone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00289	0.00445	CcSEcCtD
Drospirenone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00286	0.0044	CcSEcCtD
Drospirenone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00284	0.00436	CcSEcCtD
Drospirenone—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00283	0.00812	CbGeAlD
Drospirenone—BCHE—brain—acquired immunodeficiency syndrome	0.00281	0.00805	CbGeAlD
Drospirenone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0028	0.00431	CcSEcCtD
Drospirenone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00279	0.00429	CcSEcCtD
Drospirenone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00275	0.00423	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00274	0.00422	CcSEcCtD
Drospirenone—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.00273	0.00782	CbGeAlD
Drospirenone—BCHE—lymph node—acquired immunodeficiency syndrome	0.00271	0.00778	CbGeAlD
Drospirenone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00264	0.00406	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00252	0.00387	CcSEcCtD
Drospirenone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00243	0.00373	CcSEcCtD
Drospirenone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00226	0.00347	CcSEcCtD
Drospirenone—PTGS2—brain—acquired immunodeficiency syndrome	0.00216	0.00621	CbGeAlD
Drospirenone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00213	0.00328	CcSEcCtD
Drospirenone—PTGS2—lymph node—acquired immunodeficiency syndrome	0.00209	0.006	CbGeAlD
Drospirenone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00204	0.00314	CcSEcCtD
Drospirenone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00189	0.0029	CcSEcCtD
Drospirenone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.00279	CcSEcCtD
Drospirenone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00266	CcSEcCtD
Drospirenone—Norethindrone—ALB—acquired immunodeficiency syndrome	0.000118	0.4	CrCbGaD
Drospirenone—Methyltestosterone—ALB—acquired immunodeficiency syndrome	0.000112	0.38	CrCbGaD
Drospirenone—Testosterone—ALB—acquired immunodeficiency syndrome	6.52e-05	0.22	CrCbGaD
